Shanghai Xuerong Biological Technology Co.,Ltd. Posted 7 Million Yuan Net Loss in First Three Quarters of 2022
Listen to the full version

Shanghai Xuerong Biological Technology Co.,Ltd. (上海雪榕生物科技股份有限公司) (300511.SZ) reported a net loss of 7 million yuan in the first three quarters of 2022, narrowing 95.1% year-on-year.
Meanwhile, the company posted 1.6 billion yuan in revenue, up 15.4% year-on-year.
At the end of the reporting period, it had 4.6 billion yuan in total assets and 2.6 billion yuan in total liabilities, with a liability-to-asset ratio of 55.7%.
Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.
- PODCAST
- MOST POPULAR